This announcement is a separate document:
ノイルイミューン・バイオテック：CAR-T細胞の機能最適化技術に関するシスメックスとノイルイミューン・バイオテックの提携について
Noile-Immune Biotech: About the partnership between Sysmex and Neulimune Biotech on technology to optimize the function of CAR-T cells
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.